Cleveland, Sean Matthew,Paulik, Mark Andrew,Salomon, Stefan
申请号：
AU2013261214
公开号：
AU2013261214A1
申请日:
2013.05.16
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The disclosure relates to nanoparticles comprising poly(octylcyanoacrylate) for oral administration of a biologically active polypeptide, in particular a metabolic peptide, such as exendin-4. Also disclosed are methods of producing such nanoparticles, pharmaceutical compositions comprising such nanoparticles and methods of treating metabolic disorders, such as obesity, using such nanoparticles.
